Defective proteolysis has been implicated in hearing loss through the discovery of mutations causing autosomal recessive nonsyndromic deafness in a type II transmembrane serine protease gene, TMPRSS3. To investigate their physiological function and the contribution of this family of proteases to the auditory function, we analyzed the hearing status of mice deficient for hepsin, also known as TMPRSS1. These mice exhibited profound hearing loss with elevated hearing thresholds compared with their heterozygous and wild-type littermates. Their cochleae showed abnormal tectorial membrane development, reduction in fiber compaction in the peripheral portion of the auditory nerve, and decreased expression of the myelin proteins myelin basic protein and myelin protein zero. In addition, reduced level of the large conductance voltage-and Ca
2؉-activated K ؉ channel was detected in the sensory hair cells of Tmprss1-null mice. We examined thyroid hormone levels in Tmprss1-deficient mice, as similar cochlear defects have been reported in animal models of hypothyroidism, and found significantly reduced free thyroxine levels. These data show that TMPRSS1 is required for normal auditory function. Hearing impairment present in Tmprss1-null mice is characterized by a combination of various structural, cellular, and molecular abnormalities that are likely to affect different cochlear processes. Hearing loss occurs in approximately 1 in 1000 children, and more than half of these cases can be considered to have a genetic origin. 1 The majority of the cases of hereditary deafness (70%) are nonsyndromic where impaired auditory function is the only clinical manifestation. In addition, hearing impairment affects 50% of individuals older than 80 years.2 Most of the cases of early-onset inherited hearing loss are due to single gene defects, and it has been proposed that genes responsible for monogenically inherited hearing loss may also be implicated in age-related hearing impairment (presbyacusis).3 Therefore, identifying the genes underlying hearing loss represents a major objective of current biomedical research. Most studies on the human ear can only be performed postmortem, making the investigation of early stages of pathogenicity impossible. Thus, understanding the molecular mechanisms of normal hearing and the pathogenic processes that lead to hearing loss relies extensively on animal models. The identification and study of the function of proteins encoded by deafness genes can be performed on mouse models.Recently, defective proteolysis has been implicated in the etiology of nonsyndromic hearing loss. Indeed, we and others have reported that deleterious mutations in the TMPRSS3 gene were responsible for nonsyndromic recessive hearing loss, 4 -9 suggesting that critical signaling pathways in the inner ear are controlled by proteolytic cleavage. TMPRSS3 is a member of the type II transmembrane serine proteases (TMPRSSs)